|
Sloning Appoints Garry Merry Vice President of Commercial Operations |
PUCHHEIM/ALAMEDA, CA, April 2009 – Effective April 1st, Sloning BioTechnology has appointed Garry Merry as their new Vice President of Commercial Operations. Before joining Sloning, Mr Merry has held several executive positions in the field of sales and marketing with renowned companies such as Applied Biosystems, Millipore, or Qiagen, where he was Vice President Genomic Services.
Sloning, a world leading provider of genetic diversity, is no stranger to Mr Merry’s sales proficiency: “We used to work with Garry on the North American market only, where he was instrumental in our overwhelming success. Now, with worldwide sales expected to double for the third time in a row, we are happy to have him on board, so we can benefit from his savvy in all territories”, says Sloning CEO Dr Heinz Schwer. “This is a completely new selling experience: Sloning’s technology of creating gene mutant libraries is elegantly simple, yet so powerful, there is effectively no competition”, Mr. Merry comments, and he adds, “Customers appreciate the libraries’ superior quality and their capacity to reduce screening effort. In addition, the fee for service business model saves customers from any licensing or royalty issues. I am proud to be part of this venture that is about to change the way people do protein engineering.” About Sloning:Sloning BioTechnology specializes in the production of highly diverse and precisely engineered gene mutant libraries. Sloning’s superior genetic libraries are essential in screening for new and improved therapeutic or industrial proteins. At the heart is its core technology, Slonomics®, a patented DNA engineering platform using sets of double stranded DNA triplets. Slonomics is used to synthesize customised mutant libraries for the biopharmaceutical, industrial biotech, agri-biotech and food industries worldwide.
Sloning takes an ethical approach to synthetic biology and is a founder member of the Industry Association of Synthetic Biology (IASB) formulating industry standards for biosafety and biosecurity. |
